Ethical issues in DNA sequencing in the neonate

  • Dimmock D
  • Bick D
  • 13


    Mendeley users who have this article in their library.
  • 2


    Citations of this article.


With the recognition of genetic disorders in the newborn, there is the potential to offer new lifesaving therapies. For other conditions such as hypothyroidism in Down syndrome or hypercalemia in the 22q11 microdeltion syndrome, the early identification of an untreatable condition permits prompt screening for potential comorbid conditions. DNA testing for disorders and DNA-based screening are rapidly evolving. With new more powerful tests, there is an increasing ability to see into a potential future and change the outcome for newborns. However, there remain significant ethical and structural issues to be considered before routine implementation of DNA testing.

Author-supplied keywords

  • Newborn screening
  • Severe combined immunodeficiency polymerase chain reaction
  • Whole genome sequencing

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • David P. Dimmock

  • David P. Bick

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free